Clinical, toxicological and electroencephalographical effects of a new tricyclic antidepressant, OI-77.
D000275:Adjustment Disorders / Q000188:drug therapy*; D000328:Adult; D000639:Amitriptyline; D000928:Antidepressive Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy*; D002540:Cerebral Cortex / Q000187:drug effects; D003201:Computers; D004305:Dose-Response Relationship, Drug; D004569:Electroencephalography; D006801:Humans; D007099:Imipramine; D008297:Male; D010617:Phenanthridines / Q000009:adverse effects / Q000627:therapeutic use; D010919:Placebos; D011569:Psychiatric Status Rating Scales
D000928:Antidepressive Agents; D010617:Phenanthridines; D010919:Placebos; D000639:Amitriptyline; D007099:Imipramine